Weir Barbara, Zhao Xiaojun, Meyerson Matthew
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 44 Binney Street, Boston, Massachusetts 02115, USA.
Cancer Cell. 2004 Nov;6(5):433-8. doi: 10.1016/j.ccr.2004.11.004.
Most human malignancies are caused by somatic alterations within the cancer genome, leading to oncogene activation or tumor suppressor gene inactivation. The sequence of the human genome has enabled systematic approaches to identify cancer genome alterations, including point mutations, copy number increases and decreases, loss of allelic heterozygosity, and chromosome translocations. Systematic cancer genome analysis has recently led to the discovery of somatic mutations in the BRAF, PIK3CA, and EGFR genes, among others. With further development of targeted cancer therapies and improvement in genome analysis technology, genome-wide surveys of cancer will likely become tools for diagnosis as well as discovery.
大多数人类恶性肿瘤是由癌症基因组中的体细胞改变引起的,导致癌基因激活或肿瘤抑制基因失活。人类基因组序列使得能够采用系统方法来识别癌症基因组改变,包括点突变、拷贝数增加和减少、等位基因杂合性缺失以及染色体易位。系统的癌症基因组分析最近导致发现了BRAF、PIK3CA和EGFR等基因中的体细胞突变。随着靶向癌症治疗的进一步发展和基因组分析技术的改进,癌症的全基因组检测可能会成为诊断和发现的工具。